Ultragenyx Pharmaceutical (RARE) Share-based Compensation (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Share-based Compensation of $19.56 million for Q2 2018, up 16.5% from $16.79 million a year earlier and up 4.1% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Share-based Compensation (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2018, Ultragenyx Pharmaceutical's Share-based Compensation came in at $75.08 million, up 28.3% year-over-year; for FY2017, it came in at $68.01 million, up 40.8% from FY2016.
- Share-based Compensation has increased for four consecutive years, with a five-year compound annual growth rate of 138.0% (FY2012 to FY2017).
- By year, Share-based Compensation came in at $48.31 million in FY2016 (+94.1%), $24.88 million in FY2015 (+361.3%), $5.39 million in FY2014 (+721.0%) and $657,000 in FY2013 (-26.3%).
- The Q2 2018 figure ranks as the highest quarterly Share-based Compensation in data going back to Q1 2013.
- Year over year, Share-based Compensation has now increased in each of the last 15 quarters, with growth averaging 41.1% over the last eight quarters.
- The year-over-year growth in Share-based Compensation has ranged between 16.5% (Q2 2018) and 852.9% (Q4 2014) over the last five years.
- Per Business Quant data, the three quarters before Q2 2018 came in at $18.8 million (Q1 2018), $19.54 million (Q4 2017) and $17.18 million (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.62 Bn | -186.47 Mn | 180.00 Mn | 34.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.00 Mn |
| Mar 31, 2026 | 30.00 Mn |
| Dec 31, 2025 | 37.29 Mn |
| Sep 30, 2025 | 37.01 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Dec 31, 2024 | 40.13 Mn |
| Sep 30, 2024 | 41.57 Mn |
| Jun 30, 2024 | 39.36 Mn |
| Mar 31, 2024 | 36.93 Mn |
| Dec 31, 2023 | 33.52 Mn |
| Sep 30, 2023 | 34.88 Mn |
| Jun 30, 2023 | 34.65 Mn |
| Mar 31, 2023 | 31.95 Mn |
| Dec 31, 2022 | 29.36 Mn |
| Sep 30, 2022 | 35.76 Mn |
| Jun 30, 2022 | 35.87 Mn |
| Mar 31, 2022 | 29.40 Mn |
| Dec 31, 2021 | 26.55 Mn |
| Sep 30, 2021 | 26.99 Mn |
API Access
Ultragenyx Pharmaceutical Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();